Sunshine Biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 15474.9%.

Top 20 shareholders own 2.08% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
1.72%	Bank of America Corporation, Asset Management Arm	34,475	US$81.4k	0%	no data
0.13%	L1 Capital Pty. Limited	2,643	US$6.2k	0%	no data
0.093%	Altium Capital Management LP	1,864	US$4.4k	0%	no data
0.093%	Malek Chamoun	1,850	US$4.4k	0%	no data
0.025%	Nordwand Advisors, LLC	500	US$1.2k	0%	no data
0.0031%	Steve Slilaty	61	US$143.9	5.17%	no data
0.003%	Camille Sebaaly	60	US$141.6	0%	no data
0.0029%	Abderrazzak Merzouki	59	US$139.2	1.72%	no data
0.0005%	Geode Capital Management, LLC	10	US$23.6	0%	no data
0.00035%	National Bank Investments Inc.	7	US$16.5	133%	no data
0.00025%	Merrill Lynch & Co. Inc., Banking Investments	5	US$11.8	0%	no data
0.00005%	Securities America Advisors, Inc.	1	US$2.4	0%	no data
0.00005%	Fédération des Caisses Desjardins du Québec, Asset Management Arm	1	US$2.4	0%	no data
0.00005%	Jaffe Tilchin Investment Partners, LLC	1	US$2.4	0%	no data
0.00005%	Toronto-Dominion Bank, Banking Investments	1	US$2.4	0%	no data
0.00005%	Morgan Stanley, Investment Banking and Brokerage Investments	1	US$2.4	-98%	no data
0.00005%	Osaic Wealth, Inc. , Asset Management Arm	1	US$2.4	0%	no data
0.00005%	Farther Finance Advisors, LLC	1	US$2.4	0%	no data
0.00005%	Rise Advisors, Llc , Asset Management Arm	1	US$2.4	0%	no data
0.00005%	Rabi Kiderchah	1	US$2.4	0%	no data